Completed OBSERVATIONAL NCT01746407

Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis (EMOS)

Observational Study to Procure Human Specimens for Use in the Diagnosis and Management of Sepsis and Other Related Conditions

Sponsor: Abbott Diagnostics Division

Conditions Infection

Updated 10 times since 2017 Last updated: Dec 28, 2015 Started: Dec 31, 2012 Primary completion: Aug 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01746407, this observational or N/A phase trial focuses on Infection and remains completed. Sponsored by Abbott Diagnostics Division, it has been updated 10 times since 2012, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Diagnostics Division

Data source: Abbott Diagnostics Division

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States